Elligo Health Research® has introduced DataAI Connect, a new data and technology platform that will enable rapid, data-driven clinical research. A scalable, end-to-end data platform, DataAI Connect creates efficiencies across the clinical study workflow — reducing human error and rapidly digesting patient data to accelerate clinical trials.
“The application of AI approaches to healthcare and clinical study data is moving from the moon-shot approach to more practical applications,” said Elligo’s Chief Data Officer, Michael Ibara, Pharm.D. “An example of this approach is the process of getting patients’ medical records, which involves manual, non-scalable activities such as getting accurate information on patients’ providers, asking sites to track down records, and having humans triage hundreds of pages of medical records. The judicious and intelligent application of natural language processing (NLP), machine learning (ML), and other AI approaches increases speed, accuracy and quality, while removing the burden from the sites and patients.”
By bringing together data, processes, and clinical expertise, Elligo has created an industry first AI-driven platform that sources, processes, analyzes, and distributes patient real-world data (RWD) — meaning an end-to-end solution that solves the clinical trial challenges directly rather than being an add-on technology. The customizable, reusable platform includes:
- A RWD repository of electronic health records (EHRs) and clinical data storage that integrates EHR, clinical trial, and patient data for analytics, AI, and research.
- A complete medical records retrieval and analytics solution that transforms data in minutes into searchable, actionable insights and individual patient journey information through proper use of NLP, ML, and clinical expertise.
- A data-driven protocol development service that tests designs in the real world.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!